Sector Update: Healthcare Stocks Flat to Higher Pre-Bell Tuesday

MT NewswiresJun 16 21:21

This Zai Lab Insider Increased Their Holding By 13% Last Year

Simply Wall StJun 16 20:19

Zai Lab Announces EMA Grants Orphan Drug Designation To Zocilurtatug Pelitecan, Delta-Like Ligand 3-Targeting Antibody-Drug Conjugate, For Treatment Of Pulmonary Neuroendocrine Carcinomas

BenzingaJun 16 19:14

Zhitong Hong Kong Short Position Holding Statistics | June 12

ZHITONG Hong Kong Short Position Holdings | June 12

Zhitong FinanceJun 12 18:30

Hong Kong-listed innovative pharmaceutical stocks rose against the market trend: 3SBio gained nearly 7%, while Zai Lab and Kangzhe Pharmaceuticals both rose over 5%.

Gelonghui, June 10 | Hong Kong-listed innovative drug stocks rose against the market trend today. As of market close, Hua Hao Zhong Tian Pharmaceuticals surged nearly 29%, 3SBio gained nearly 7%, Zai Lab and Hansoh Pharmaceutical rose over 5%, LegoChem Biosciences and Livzon Pharmaceutical climbed over 4%, and CSPC Pharma, InnoCare Pharma, Kelun-Biotech, China Resources Pharma, Wuxi Apptec, and Ascentage Pharma all advanced over 3%. Simcere Pharmaceutical, Hansoh Pharmaceutical, BeiGene, and Grand Pharmaceutical gained more than 2%.

Gelonghui FinanceJun 10 16:20

Market Snapshot | All three major indices declined, with the Hang Seng Tech Index down 0.94%; southbound capital flowed into Hong Kong markets, net buying over HK$8.2 billion. Some tech and internet stocks rose against the market trend, with Tencent up ne

All three major indices declined, with the Hang Seng Tech Index down 0.94%; tech and internet stocks rose, led by NetEase-S up 3.79%; most semiconductor stocks fell, with Innoscience down 13.39%.

Futu NewsJun 10 16:17